Bala Mohan (CIK 1991787) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Sell MRSN (2,927 shares), Buy MRSN (250 shares), Sell MRSN (77 shares), Buy MRSN (14,583 shares), Sell MRSN (5,939 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development | Sell | 2,927 | $0 |
| 2025-10-28 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development Officer | Buy | 250 | $0 |
| 2025-10-28 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development Officer | Sell | 77 | $762 |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development Officer | Buy | 14,583 | $0 |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development Officer | Sell | 5,939 | $3,445 |
| 2025-01-15 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development Officer | Buy | 8,750 | $0 |
| 2025-01-15 | Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development Officer | Sell | 3,253 | $2,147 |
Source: SEC Form 4 filings · as of 2026-01-06